Biliary interleukin-6 and tumor necrosis factor-alpha in patients undergoing endoscopic retrograde cholangiopancreatography

被引:44
作者
Rosen, HR
Winkle, PJ
Kendall, BJ
Diehl, DL
机构
[1] UNIV CALIF LOS ANGELES,DIV DIGEST DIS,LOS ANGELES,CA 90024
[2] OREGON HLTH SCI UNIV,PORTLAND,OR 97201
关键词
interleukin-6; tumor necrosis factor-alpha; cholangiopancreatography;
D O I
10.1023/A:1018822628096
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Cytokines are low-molecular-weight protein mediators that possess a wide spectrum of inflammatory, metabolic, and immunomodulatory properties. Cytokines have been shown to be produced by monocytes/macrophages, Lymphocytes, fibroblasts, endothelial cells, and more recently, hepatocytes and biliary epithelium The aim of this study was to define biliary levels of interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-alpha) in patients undergoing endoscopic retrograde cholangiopancreatography (ERCP) in various disease states. Fifty-four patients undergoing ERCP comprised the study group, IL-6 and TNF-alpha were measured in aspirated bile using an ELISA technique. Levels of both TNF-alpha and IL-6 were significantly higher in patients with cholangitis (P < 0.00001). Moreover, IL-6 was 100% specific for cholangitis sind none of the patients without bacterial cholangitis-including patients with biliary obstruction secondary to cholangiocarcinoma or pancreatic carcinoma-had measurable IL-6 in their bile. Low-levels of biliary TNF-alpha were detectable in five patients without cholangitis: the sensitivity and specificity of TNF-alpha for cholangitis were 100% and 82%, respectively. There was a strong statistical correlation between biliary IL-6 and TNF-alpha levels (r = 0.819, P < 0.0001). In contrast, the correlations between biliary cytokines and serum biochemical parameters were weak. These results suggest that IL-6 and TNF-alpha are sensitive markers for cholangitis and may differentiate it from other types of biliary tract disease.
引用
收藏
页码:1290 / 1294
页数:5
相关论文
共 22 条
[1]
HIGH-CONCENTRATIONS OF SOLUBLE TUMOR-NECROSIS-FACTOR RECEPTORS IN ASCITES [J].
ANDUS, T ;
GROSS, V ;
HOLSTEGE, A ;
OTT, M ;
WEBER, M ;
DAVID, M ;
GALLATI, H ;
GEROK, W ;
SCHOLMERICH, J .
HEPATOLOGY, 1992, 16 (03) :749-755
[2]
Increased concentrations of tumour necrosis factor (TNF) and soluble TNF receptors in biliary obstruction in mice; Soluble TNF receptors as prognostic factors for mortality [J].
Bemelmans, MHA ;
Greve, JWM ;
Gouma, DJ ;
Buurman, WA .
GUT, 1996, 38 (03) :447-453
[3]
TUMOR-NECROSIS-FACTOR-ALPHA AND INTERLEUKIN-6 PLASMA-LEVELS IN INFECTED CIRRHOTIC-PATIENTS [J].
BYL, B ;
ROUCLOUX, I ;
CRUSIAUX, A ;
DUPONT, E ;
DEVIERE, J .
GASTROENTEROLOGY, 1993, 104 (05) :1492-1497
[4]
CHROUSOS GP, 1995, NEW ENGL J MED, V333, P942
[5]
RECOMBINANT INTERLEUKIN-1 RECEPTOR ANTAGONIST BLOCKS THE PROINFLAMMATORY ACTIVITY OF ENDOGENEOUS INTERLEUKIN-1 IN RABBIT IMMUNE COLITIS [J].
COMINELLI, F ;
NAST, CC ;
DUCHINI, A ;
LEE, M .
GASTROENTEROLOGY, 1992, 103 (01) :65-71
[6]
ENGLEBERTS I, 1991, LANCET, V338, P515
[7]
FONG Y, 1990, SURG GYNECOL OBSTET, V170, P363
[8]
GIONCHETTI P, 1994, AM J GASTROENTEROL, V89, P883
[9]
HILL DB, 1992, J LAB CLIN MED, V119, P547
[10]
INTERLEUKIN-6 IN SYNOVIAL-FLUID AND SERUM OF PATIENTS WITH RHEUMATOID-ARTHRITIS AND OTHER INFLAMMATORY ARTHRITIDES [J].
HOUSSIAU, FA ;
DEVOGELAER, JP ;
VANDAMME, J ;
DEDEUXCHAISNES, CN ;
VANSNICK, J .
ARTHRITIS AND RHEUMATISM, 1988, 31 (06) :784-788